Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1016/s2468-1253(21)00347-2

Type

Journal

The lancet. Gastroenterology & hepatology

Publication Date

12/2021

Volume

6

Addresses

Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK; Faculty of Medicine, Imperial College London, London, UK.

Keywords

Humans, Inflammatory Bowel Diseases, Immunosuppressive Agents, Biological Therapy, Immunocompromised Host, Adult, Aged, Aged, 80 and over, Middle Aged, Patient Acceptance of Health Care, Female, Male, United Kingdom, Vaccination Refusal, Vaccination Coverage, COVID-19, COVID-19 Vaccines